MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma
Blinatumomab for relapsed/refractory Burkitt's lymphoma
Using bioinformatics and genomics to treat AML
The changing landscape of AML
CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL
Lymphodepleting chemotherapy in order to safely improve the expansion of HER2-CAR T cells in patients with advanced sarcomas
New developments in soft tissue and bone sarcoma research
Patient treatment preferences in relapsed/refractory multiple myeloma
The international myeloma working group frailty score for elderly patients with multiple myeloma
Osteoporosis and osteopenia in elderly patients
Treating myelodysplastic syndromes
Four studies about relapsed myeloma and advanced disease